◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF (H411) ETF Overview

Name: HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF (H411) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-02

HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF (H411) is an exchange-traded fund managed by HSBC Investment Funds (Luxembourg) S.A.. It manages roughly €361 million in assets.

Interactive chart & fund stats →

H411 Fund Statistics

Expense ratio	0.45%
Assets under management	€361 million
Fund family	HSBC Investment Funds (Luxembourg) S.A.
Inception	2022-07-12

The live price chart, fund profile and news are in the interactive H411 viewer.

Other Companies in —

DJAM · Amundi Dow Jones Industrial Average UCITS ETF Dist — €366 million
DJEL · Amundi Dow Jones Industrial Average UCITS ETF Dist — £366 million
MWOA · Amundi ETF ICAV - Amundi S&P World Industrials Screened UCITS ETF Dist — $362 million
WEL0 · Amundi ETF ICAV - Amundi S&P World Industrials Screened UCITS ETF Acc — $362 million
CMMF · Amundi EUR Cash Active UCITS ETF EUR Acc — €360 million
EXI3 · iShares Dow Jones Industrial Average UCITS ETF (DE) — €359 million
ELFA · Deka EURO STOXX 50 ESG Filtered UCITS ETF — €359 million
ZPRE · State Street SPDR MSCI EMU UCITS ETF — €359 million

← H410 All “H” companies H412 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.